Compare RXST & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RXST | SAR |
|---|---|---|
| Founded | 1997 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.8M | 200.7M |
| IPO Year | 2021 | 2006 |
| Metric | RXST | SAR |
|---|---|---|
| Price | $5.08 | $12.72 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 10 | 7 |
| Target Price | $6.10 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 863.5K | 133.8K |
| Earning Date | 11-03-2026 | 10-06-2026 |
| Dividend Yield | N/A | ★ 23.79% |
| EPS Growth | N/A | ★ 14.36 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.02 | $0.78 |
| Revenue Next Year | N/A | $6.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.11 | $12.60 |
| 52 Week High | $13.22 | $24.07 |
| Indicator | RXST | SAR |
|---|---|---|
| Relative Strength Index (RSI) | 54.28 | 28.56 |
| Support Level | $4.47 | N/A |
| Resistance Level | $5.45 | $14.27 |
| Average True Range (ATR) | 0.35 | 0.45 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 71.91 | 11.45 |
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.